FEATURED PRODUCT:  Interpretation of FDA's (QSR) With QSIT references

Example frontpage imageA complete compendium to FDA's Quality System Regulation (QSR) with relative references to FDA's Quality System Inspection Technique (QSIT) ONLY $99.  


Developing policies and procedures
Preparing for FDA audits
Responding to 483 Observations and Warning Letters
Conducting Internal Audits or determining Gap Analysis  

 

 

Search This Site

 

 

Johnson & Johnson Buys Synthes  

 

Paying $21.3 Billion Johnson and Johnson purchased Synthes to boost presence in Trauma market. According to Chief Executive Officer Bill Weldon the Acquisition will effectively position J&J as the the majority in the trauma market.

Weldon went on to say “Very infrequently do you ever see an opportunity for a company like Synthes to come into play with J&J....We just thought this was an extraordinary opportunity and the time was right.”

Alex Gorsky, vice chairman of J&J’s executive committee said "We believe we will not be any required to make any divestitures and if there are any, they will not materially impact the transaction.” He indicated that the acquisition will move to benefit the industry including medical practitioner because it will stimulate competition.

The purchase was the biggest in Johnson & Johnson's 125 year history and is expected to corner the $5.5 Billion dollar Trauma market.

  
 

 

 

Site Map »

Media package available for advertisers looking to advertise on this site.